PURPOSE: Genetic variation may influence chemotherapy response and overall survival in cancer patients. EXPERIMENTAL DESIGN: We conducted a genome-wide scan in 535 advanced-stage non-small cell lung cancer (NSCLC) patients from two independent cohorts (307 from Nanjing and 228 from Beijing). A replication was carried out on an independent cohort of 340 patients from Southeastern China followed by a second validation on 409 patients from the Massachusetts General Hospital (Boston, MA). RESULTS: Consistent associations with NSCLC survival were identified for five single-nucleotide polymorphisms (SNP) in Chinese populations with P values ranging from 3.63 × 10(-5) to 4.19 × 10(-7) in the additive genetic model. The minor allele of three SNPs (rs7629386 at 3p22.1, rs969088 at 5p14.1, and rs3850370 at 14q24.3) were associated with worse NSCLC survival while 2 (rs41997 at 7q31.31 and rs12000445 at 9p21.3) were associated with better NSCLC survival. In addition, rs7629386 at 3p22.1 (CTNNB1) and rs3850370 at 14q24.3 (SNW1-ALKBH1-NRXN3) were further replicated in the Caucasian population. CONCLUSION: In this three-stage genome-wide association studies, we identified five SNPs as markers for survival of advanced-stage NSCLC patients treated with first-line platinum-based chemotherapy in Chinese Han populations. Two of these SNPs, rs7629386 and rs3850370, could also be markers for survival among Caucasian patients.
PURPOSE: Genetic variation may influence chemotherapy response and overall survival in cancerpatients. EXPERIMENTAL DESIGN: We conducted a genome-wide scan in 535 advanced-stage non-small cell lung cancer (NSCLC) patients from two independent cohorts (307 from Nanjing and 228 from Beijing). A replication was carried out on an independent cohort of 340 patients from Southeastern China followed by a second validation on 409 patients from the Massachusetts General Hospital (Boston, MA). RESULTS: Consistent associations with NSCLC survival were identified for five single-nucleotide polymorphisms (SNP) in Chinese populations with P values ranging from 3.63 × 10(-5) to 4.19 × 10(-7) in the additive genetic model. The minor allele of three SNPs (rs7629386 at 3p22.1, rs969088 at 5p14.1, and rs3850370 at 14q24.3) were associated with worse NSCLC survival while 2 (rs41997 at 7q31.31 and rs12000445 at 9p21.3) were associated with better NSCLC survival. In addition, rs7629386 at 3p22.1 (CTNNB1) and rs3850370 at 14q24.3 (SNW1-ALKBH1-NRXN3) were further replicated in the Caucasian population. CONCLUSION: In this three-stage genome-wide association studies, we identified five SNPs as markers for survival of advanced-stage NSCLCpatients treated with first-line platinum-based chemotherapy in Chinese Han populations. Two of these SNPs, rs7629386 and rs3850370, could also be markers for survival among Caucasian patients.
Authors: Anna L Dixon; Liming Liang; Miriam F Moffatt; Wei Chen; Simon Heath; Kenny C C Wong; Jenny Taylor; Edward Burnett; Ivo Gut; Martin Farrall; G Mark Lathrop; Gonçalo R Abecasis; William O C Cookson Journal: Nat Genet Date: 2007-09-16 Impact factor: 38.330
Authors: Shaun Purcell; Benjamin Neale; Kathe Todd-Brown; Lori Thomas; Manuel A R Ferreira; David Bender; Julian Maller; Pamela Sklar; Paul I W de Bakker; Mark J Daly; Pak C Sham Journal: Am J Hum Genet Date: 2007-07-25 Impact factor: 11.025
Authors: Jian Gu; David Berman; Charles Lu; Ignacio I Wistuba; Jack A Roth; Marsha Frazier; Margaret R Spitz; Xifeng Wu Journal: Clin Cancer Res Date: 2006-12-15 Impact factor: 12.531
Authors: Carissa C Jones; William S Bush; Dana C Crawford; Angela S Wenzlaff; Ann G Schwartz; John K Wiencke; Margaret R Wrensch; William J Blot; Stephen J Chanock; Eric L Grogan; Melinda C Aldrich Journal: Cancer Epidemiol Biomarkers Prev Date: 2017-06-15 Impact factor: 4.254
Authors: Yanru Wang; Hongliang Liu; Neal E Ready; Li Su; Yongyue Wei; David C Christiani; Qingyi Wei Journal: Int J Cancer Date: 2016-01-30 Impact factor: 7.396
Authors: Joel L Weissfeld; Brenda Diergaarde; Tomoko Nukui; Shama Buch; Arjun Pennathur; Mark A Socinski; Jill M Siegfried; Marjorie Romkes Journal: J Thorac Oncol Date: 2014-09 Impact factor: 15.609
Authors: S Cao; S Wang; H Ma; S Tang; C Sun; J Dai; C Wang; Y Shu; L Xu; R Yin; X Song; H Chen; B Han; Q Li; J Wu; C Bai; J Chen; G Jin; Z Hu; D Lu; H Shen Journal: Pharmacogenomics J Date: 2015-03-31 Impact factor: 3.550
Authors: Jian-Yue Jin; Weili Wang; Randall K Ten Haken; Jie Chen; Nan Bi; Ramses Sadek; Hong Zhang; Theodore S Lawrence; Feng-Ming Spring Kong Journal: Radiother Oncol Date: 2015-08-04 Impact factor: 6.280
Authors: Xia Pu; Jack A Roth; Michelle A T Hildebrandt; Yuanqing Ye; Hua Wei; John D Minna; Scott M Lippman; Xifeng Wu Journal: Cancer Res Date: 2013-02-01 Impact factor: 12.701